ClinicalTrials.Veeva

Menu

Cryosurvival of Embryos From Dysmorphic Oocytes

V

V.K.V. American Hospital, Istanbul

Status

Completed

Conditions

Blastocyst
Cryopreservation

Treatments

Procedure: Cryopreservation, thawing and blastocyst culture

Study type

Observational

Funder types

Other

Identifiers

NCT00521443
AH-05/04

Details and patient eligibility

About

Various morphological abnormalities of human oocytes were reported to detrimentally affect embryo development. We observed development of frozen thawed embryos derived from oocytes with normal or abnormal morphological features to the blastocyst stage. Cytoplasmic abnormalities of the oocytes were found to negatively affect cryosurvival potential of the embryos.

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Human embryos derived from morphologically normal or abnormal mature oocytes that fertilized normally by microinjection procedure.
  • Embryos were obtained from couples who refused to freeze their supernumerary embryos after fresh embryo transfer in an assisted reproduction treatment cycle.

Exclusion criteria

  • Embryos obtained after microinjection to immature oocytes taht were in vitro matured in culture.
  • Embryos obtained from abnormally fertilized zygotes.

Trial design

0 participants in 12 patient groups

Normal
Description:
Embryos derived from morphologically normal MII oocytes
Treatment:
Procedure: Cryopreservation, thawing and blastocyst culture
Irregular Shapes
Description:
Embryos derived from irregularly shaped oocytes.
Treatment:
Procedure: Cryopreservation, thawing and blastocyst culture
Large PVS
Description:
Embryos derived from oocytes with large perivitelline space.
Treatment:
Procedure: Cryopreservation, thawing and blastocyst culture
Dark Zona
Description:
Embryos derived from oocytes with dark zona pellucida
Treatment:
Procedure: Cryopreservation, thawing and blastocyst culture
Dark cytoplasm
Description:
Embryos derived from oocytes with dark cytoplasm
Treatment:
Procedure: Cryopreservation, thawing and blastocyst culture
Vacuolar cytoplasm
Description:
Embryos derived from oocytes with vacuolated cytoplasm
Treatment:
Procedure: Cryopreservation, thawing and blastocyst culture
Central granulation
Description:
Embryos derived from oocytes with centrally granulated cytoplasm
Treatment:
Procedure: Cryopreservation, thawing and blastocyst culture
Double extra
Description:
Embryos derived from oocytes with double extracytoplasmic abnormalities
Treatment:
Procedure: Cryopreservation, thawing and blastocyst culture
Double combined
Description:
Embryos derived from oocytes with any combination of one extracytoplasmic and one cytoplasmic anomaly
Treatment:
Procedure: Cryopreservation, thawing and blastocyst culture
Double cytoplasmic
Description:
Embryos derived from oocytes with any two cytoplasmic anomalies
Treatment:
Procedure: Cryopreservation, thawing and blastocyst culture
Triple extra
Description:
Embryos derived from oocytes with triple extracytoplasmic anomaly
Treatment:
Procedure: Cryopreservation, thawing and blastocyst culture
Triple combined
Description:
Embryos derived from oocytes with triple combined anomalies
Treatment:
Procedure: Cryopreservation, thawing and blastocyst culture

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems